angiotensin ii, sar(1)-me-tyr(4)- has been researched along with angiotensin ii in 21 studies
Studies (angiotensin ii, sar(1)-me-tyr(4)-) | Trials (angiotensin ii, sar(1)-me-tyr(4)-) | Recent Studies (post-2010) (angiotensin ii, sar(1)-me-tyr(4)-) | Studies (angiotensin ii) | Trials (angiotensin ii) | Recent Studies (post-2010) (angiotensin ii) |
---|---|---|---|---|---|
25 | 0 | 0 | 38,152 | 1,089 | 7,413 |
6 | 0 | 0 | 38,152 | 1,089 | 7,413 |
Protein | Taxonomy | angiotensin ii, sar(1)-me-tyr(4)- (IC50) | angiotensin ii (IC50) |
---|---|---|---|
Atrial natriuretic peptide receptor 3 | Homo sapiens (human) | 0.002 | |
Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.002 | |
Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0018 | |
Type-1 angiotensin II receptor | Homo sapiens (human) | 0.0055 | |
Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.004 | |
Type-2 angiotensin II receptor | Homo sapiens (human) | 0.0011 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (33.33) | 18.7374 |
1990's | 9 (42.86) | 18.2507 |
2000's | 5 (23.81) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Entzeroth, M; Mauz, AB; Van Meel, JC; Wienen, W | 1 |
Moore, GJ; Sharma, RK; Smith, JR | 1 |
Cordopatis, P; Franklin, KJ; Ganter, RC; Hondrelis, J; Matsoukas, J; Moore, GJ | 1 |
Criscione, L; de Gasparo, M; Kamber, B; Thomann, H; Whitebread, S | 1 |
Belte, U; Cordopatis, P; Franklin, KJ; Ganter, RC; Goghari, MH; Matsoukas, J; Moore, GJ | 1 |
Koziarz, P; Moore, GJ | 1 |
Bovy, PR; McMahon, EG; Palomo, M; Trapani, AJ | 1 |
Moore, GJ; Scanlon, MN | 1 |
Franklin, KJ; Goghari, MH; Moore, GJ | 1 |
Franklin, KJ; Moore, GJ; Nystrom, DM | 1 |
Franklin, KJ; Matsoukas, JM; Moore, GJ; Scanlon, MN | 1 |
Agelis, G; Ganter, R; Hondrelis, J; Matsoukas, JM; Moore, D; Moore, GJ; Smith, JR; Wu, Q; Yamdagni, R | 1 |
Georgiev, VP; Tchekalarova, JD | 1 |
Georgiev, V; Tchekalarova, J | 1 |
Georgiev, V; Georgieva, D | 1 |
Kolocouris, A; Matsoukas, J; Mavromoustakos, T; Roumelioti, P; Weisemann, R; Zervou, M | 1 |
Alexopoulos, K; Kolocouris, A; Matsoukas, JM; Mavromoustakos, T; Moore, GJ; Roumelioti, P; Tselios, T | 1 |
Alova, L; Georgiev, V; Stancheva, S | 1 |
Georgiev, V; Kambourova, T; Matsoukas, J; Pechlivanova, D; Tchekalarova, J | 1 |
Alova, L; Georgiev, V; Stancheva, S; Velkova, M | 1 |
Benetis, NP; Giatas, N; Grdadolnik, SG; Kolocouris, A; Kyrikou, I; Matsoukas, J; Mavromoustakos, T; Minakakis, PM; Polevaya, L; Roumelioti, P; Vlahakos, D; Zervou, M; Zoga, A; Zoumpoulakis, P | 1 |
1 review(s) available for angiotensin ii, sar(1)-me-tyr(4)- and angiotensin ii
Article | Year |
---|---|
Conformation and bioactivity. Design and discovery of novel antihypertensive drugs.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Drug Design; Humans; Hypertension; Losartan; Magnetic Resonance Spectroscopy; Molecular Conformation; Molecular Mimicry; Peptides; Structure-Activity Relationship | 2004 |
20 other study(ies) available for angiotensin ii, sar(1)-me-tyr(4)- and angiotensin ii
Article | Year |
---|---|
Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta, Thoracic; Binding Sites; Biphenyl Compounds; Female; Imidazoles; In Vitro Techniques; Iodine Radioisotopes; Kinetics; Losartan; Male; Muscle Contraction; Peptides; Rabbits; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Tetrazoles | 1992 |
Inhibition of bovine brain calmodulin-dependent cGMP phosphodiesterase by peptide and non-peptide angiotensin receptor ligands.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Brain; Cattle; Cell Membrane; Cyclic Nucleotide Phosphodiesterases, Type 1; Female; Kinetics; Molecular Structure; Phosphoric Diester Hydrolases; Rats; Receptors, Angiotensin; Uterus | 1991 |
Synthesis and biological activities of angiotensin II and Sarmesin analogues containing cyclohexylalanine.
Topics: Angiotensin II; Animals; Female; In Vitro Techniques; Phenylalanine; Rats; Structure-Activity Relationship; Uterine Contraction | 1991 |
Sarmesin is a partial agonist of angiotensin-II receptors in rabbit, but not in rat, aortic rings.
Topics: Angiotensin II; Animals; Aorta; In Vitro Techniques; Kinetics; Muscle Contraction; Muscle, Smooth, Vascular; Rabbits; Rats; Receptors, Angiotensin; Species Specificity | 1990 |
Importance of the N-terminal domain of the type II angiotensin antagonist sarmesin for receptor blockade.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arginine; Biological Assay; Chemical Phenomena; Chemistry; Female; Isoleucine; Methylation; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Sarcosine; Structure-Activity Relationship; Uterus | 1988 |
On the mechanism of action of sarmesin and sarilesin at angiotensin receptors in smooth muscle.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Female; In Vitro Techniques; Muscle, Smooth; Rats; Rats, Inbred Strains; Receptors, Angiotensin | 1989 |
A carboxy-terminus truncated analogue of angiotensin II, [Sar1]angiotensin II-(1-7)-amide, provides an entry to a new class of angiotensin II antagonists.
Topics: Angiotensin II; Animals; Blood Pressure; In Vitro Techniques; Peptide Fragments; Rabbits; Rats; Saralasin; Structure-Activity Relationship; Vasoconstriction | 1989 |
Classification of angiotensin receptors in rat isolated uterus, portal vein, and aorta with the novel competitive antagonist sarmesin.
Topics: Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Aorta, Thoracic; Female; Heart Rate; In Vitro Techniques; Male; Muscle, Smooth; Muscle, Smooth, Vascular; Portal Vein; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Uterus | 1988 |
Structure-activity relationships for the competitive angiotensin antagonist [sarcosine,O-methyltyrosine4]angiotensin II (sarmesin).
Topics: Angiotensin II; Animals; Female; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1986 |
Structure dependence of angiotensin tachyphylaxis and the mechanisms of saralasin like and sarmesin like antagonism.
Topics: Angiotensin II; Animals; Female; Rats; Saralasin; Structure-Activity Relationship; Tachyphylaxis | 1985 |
A new approach to angiotensin antagonists: methylation of the tyrosine hydroxyl in angiotensin II.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin II; Animals; Blood Pressure; Female; In Vitro Techniques; Rats; Rats, Inbred Strains; Uterine Contraction | 1984 |
Synthesis and biological activities of angiotensin II, Sarilesin, and Sarmesin analogues containing Aze or Pip at position 7.
Topics: Angiotensin II; Animals; Azetidinecarboxylic Acid; Chromatography, High Pressure Liquid; Female; Pipecolic Acids; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Structure-Activity Relationship; Uterus | 1993 |
Interaction of angiotensin II and adenosine receptors in pentylenetetrazol-induced kindling in mice.
Topics: Analysis of Variance; Angiotensin II; Animals; Convulsants; Epilepsy, Tonic-Clonic; Kindling, Neurologic; Male; Mice; Mice, Inbred ICR; Pentylenetetrazole; Reaction Time; Receptors, Purinergic P1 | 1998 |
Further evidence for interaction between angiotensin II and dopamine receptors (experiments on apomorphine stereotypy).
Topics: Angiotensin II; Animals; Apomorphine; Losartan; Male; Rats; Rats, Wistar; Receptors, Dopamine; Stereotyped Behavior | 1998 |
The role of angiotensin II and of its receptor subtypes in the acetic acid-induced abdominal constriction test.
Topics: Acetic Acid; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Colic; Imidazoles; Losartan; Male; Mice; Mice, Inbred ICR; Pain; Pain Measurement; Pyridines; Receptors, Angiotensin; Saralasin | 1999 |
An effort to understand the molecular basis of hypertension through the study of conformational analysis of losartan and sarmesin using a combination of nuclear magnetic resonance spectroscopy and theoretical calculations.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Hypertension; Losartan; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Monte Carlo Method; Protein Conformation | 1999 |
Structural comparison between type I and type II antagonists: possible implications in the drug design of AT1 antagonists.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Drug Design; Female; Magnetic Resonance Spectroscopy; Models, Molecular; Rats; Receptors, Angiotensin; Structure-Activity Relationship; Uterus | 2000 |
The effects of peptide and nonpeptide angiotensin II-receptor ligands on the activity of brain monoamine oxidase in water-repleted rats.
Topics: Angiotensin II; Animals; Body Water; Brain; Drinking; Imidazoles; Isoenzymes; Ligands; Losartan; Male; Monoamine Oxidase; Peptides; Rats; Rats, Wistar; Receptors, Angiotensin; Tetrazoles | 2000 |
The effects of sarmesin, an Angiotensin II analogue on seizure susceptibility, memory retention and nociception.
Topics: Angiotensin II; Animals; Avoidance Learning; Disease Models, Animal; Drug Combinations; Imidazoles; Injections, Intraventricular; Kindling, Neurologic; Losartan; Male; Memory; Mice; Pain Measurement; Pentylenetetrazole; Pyridines; Seizures; Tail | 2003 |
The effects of peptide and nonpeptide antagonists of angiotensin II receptors on the noradrenaline uptake of different brain structures in rats with angiotensin II-induced increase of water intake.
Topics: Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Brain; Drinking Behavior; Imidazoles; Losartan; Male; Norepinephrine; Rats; Rats, Wistar; Saralasin; Tetrazoles | 2003 |